Company profile for Tetraphase Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

According to The Review on Antimicrobial Resistance, published in May 2016, by 2050, antimicrobial resistance is projected to kill more people than cancer and diabetes combined. At Tetraphase, the fight against antimicrobial resistance is at the core of who we are as a company. It unites us in a common goal and fuels our determination to develop new antibiotics that can overcome the challenges of drug-resistant bacteria and en...
According to The Review on Antimicrobial Resistance, published in May 2016, by 2050, antimicrobial resistance is projected to kill more people than cancer and diabetes combined. At Tetraphase, the fight against antimicrobial resistance is at the core of who we are as a company. It unites us in a common goal and fuels our determination to develop new antibiotics that can overcome the challenges of drug-resistant bacteria and ensure the availability of effective treatments in the future.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
480 Arsenal Way, Suite 110, Watertown, MA 02472
Telephone
Telephone
617-715-3600
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://endpts.com/tetraphase-deal-done-la-jolla-pharmaceutical-taps-larry-edwards-as-ceo-longtime-eli-lilly-exec-michael-overdorf-heads-to-annexon-as-cbo/

Kathy Wong ENDPTS
30 Jul 2020

https://www.businesswire.com/news/home/20200624005287/en

BUSINESSWIRE
24 Jun 2020

https://www.businesswire.com/news/home/20200622005209/en

BUSINESSWIRE
22 Jun 2020

https://endpts.com/as-it-happened-a-bidding-war-for-an-antibiotic-maker-in-a-market-that-has-ravaged-its-peers/

Natalie Grover ENDPTS
05 Jun 2020

https://www.businesswire.com/news/home/20200604005453/en

BUSINESSWIRE
04 Jun 2020

https://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-announces-it-will-not-further-revise-its-offer-to-acquire-tetraphase-301070465.html

PRNEWSWIRE
03 Jun 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty